$70.02
0.610.88%
In chiusura: -
$70.02
0.000.00%
After hour: Oct 24, 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Mirum Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.140
Stima dei ricavi trimestrali
$131.06M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$429.16M
Analizza lo storico degli utili di Mirum Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals | -$0.30 | -$0.14 | — | — | $90.38M | $131.06M | — | — | 11/11/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.52 | -$0.32 | -$0.12 | 62.50% | $77.88M | $108.22M | $127.78M | 18.08% | 08/06/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.54 | -$0.27 | -$0.30 | -11.11% | $69.22M | $98.40M | $111.60M | 13.41% | 05/07/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.66 | -$0.25 | -$0.49 | -96.00% | $69.55M | $96.64M | $99.41M | 2.87% | 02/26/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.57 | -$0.45 | -$0.30 | 33.33% | $47.73M | $82.01M | $90.38M | 10.20% | 11/12/2024 | |
MIRM | Mirum Pharmaceuticals | -$1.94 | -$0.47 | -$0.52 | -10.64% | $37.50M | $75.25M | $77.88M | 3.49% | 08/07/2024 | |
MIRM | Mirum Pharmaceuticals | -$0.80 | -$0.48 | -$0.54 | -12.50% | $31.60M | $70.17M | $69.22M | -1.35% | 05/08/2024 | |
MIRM | Mirum Pharmaceuticals | -$0.99 | -$0.24 | -$0.66 | -175.00% | $27.91M | $67.76M | $69.55M | 2.65% | 02/28/2024 | |
MIRM | Mirum Pharmaceuticals | -$1.02 | -$0.65 | -$0.57 | 12.31% | $18.78M | $37.12M | $47.73M | 28.57% | 11/02/2023 | |
MIRM | Mirum Pharmaceuticals | -$0.84 | -$0.81 | -$1.94 | -139.51% | $17.48M | $30.00M | $37.50M | 24.99% | 08/03/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.17 | -$0.94 | -$0.80 | 14.89% | $12.89M | $28.69M | $31.60M | 10.14% | 05/04/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.65 | -$1.02 | -$0.99 | 2.94% | $3.14M | $24.57M | $27.91M | 13.58% | 03/08/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.55 | -$1.07 | -$1.02 | 4.67% | $5.00M | $20.81M | $18.78M | -9.75% | 11/09/2022 | |
MIRM | Mirum Pharmaceuticals | -$1.45 | -$1.15 | -$0.84 | 26.96% | $11.00M | $15.42M | $17.48M | 13.39% | 08/04/2022 | |
MIRM | Mirum Pharmaceuticals | $1.68 | -$1.34 | -$1.17 | 12.69% | $0.00 | $8.46M | $12.89M | 52.39% | 05/05/2022 | |
MIRM | Mirum Pharmaceuticals | -$1.43 | $0.34 | -$1.65 | -585.29% | $0.00 | $62.65M | $3.14M | -94.99% | 03/09/2022 | |
MIRM | Mirum Pharmaceuticals | -$0.86 | -$1.73 | -$1.55 | 10.40% | $0.00 | $830.00K | $5.00M | 502.41% | 11/15/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.93 | — | -$1.45 | — | $0.00 | $14.50M | $11.00M | -24.14% | 08/05/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.86 | -$0.69 | $1.68 | 343.48% | $0.00 | $8.33M | $0.00 | -100.00% | 05/06/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.79 | — | -$1.43 | — | $0.00 | — | $0.00 | — | 03/09/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.84 | — | -$0.86 | — | $0.00 | — | $0.00 | — | 11/12/2020 |
Mirum Pharmaceuticals (MIRM) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $-0.12 | $-0.32 | 62.5 % |
| Q1 | 2025-05-07 | $-0.30 | $-0.27 | -11.1 % |
| Q4 | 2025-02-26 | $-0.49 | $-0.25 | -96.0 % |
| Q3 | 2024-11-12 | $-0.30 | $-0.45 | 33.3 % |
Mirum Pharmaceuticals (MIRM) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $127.79M | $108.22M | 18.1 % |
| Q1 | 2025-05-07 | $111.60M | $98.40M | 13.4 % |
| Q4 | 2025-02-26 | $99.41M | $96.64M | 2.87 % |
| Q3 | 2024-11-12 | $90.38M | $82.01M | 10.2 % |
FAQ
Quando Mirum Pharmaceuticals (NASDAQ:MIRM) riporterà gli utili?
Si prevede che Mirum Pharmaceuticals (MIRM) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Mirum Pharmaceuticals (NASDAQ:MIRM)?
L'EPS effettivo era $-0.12, che superato la stima di $-0.32.
Quali sono state le entrate di Mirum Pharmaceuticals (NASDAQ:MIRM)?
Le entrate effettive sono state $127.8M, che superato la stima di $108.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.